Heterogeneity of Clinical N1 Non-Small Cell Lung Cancer

被引:9
|
作者
Kim, Dohun [1 ]
Choi, Yong Soo [1 ]
Kim, Hong Kwan [1 ]
Kim, Kwhanmien [2 ]
Kim, Jhingook [1 ]
Shim, Young Mog [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Dept Thorac Surg, Samsung Med Ctr, Seoul 135710, South Korea
[2] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Thorac Surg, Seoul, South Korea
来源
THORACIC AND CARDIOVASCULAR SURGEON | 2014年 / 62卷 / 02期
关键词
lung cancer; diagnosis (includes staging; imaging; and fiducial); lung cancer treatment (surgery and medicine); positron emission tomography; POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; LYMPH-NODE INVOLVEMENT; PROGNOSTIC-SIGNIFICANCE; STAGING PROJECT; FDG-PET; CT; CLASSIFICATION; ACCURACY;
D O I
10.1055/s-0032-1333067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThere have been many reports of N1 node metastasis on computed tomography (CT) scan, but not on positron emission tomography (PET)-CT in nonsmall cell lung cancer. The aim of this study was to analyze the clinicopathologic correlation and survival of N1 disease on preoperative PET-CT. MethodsFrom January 2003 to December 2007, 1,748 curative lung resections were performed at a single institute. We enrolled 91 patients with clinical N1 on PET-CT. All the enrolled patients had undergone pulmonary resection with mediastinal lymph node dissection. According to the preoperative PET-CT, we classified the patients into two groups: those with single N1 metastasis (cN1a, n=91) and those with multiple N1 metastases (cN1b, n=8). Clinicopathologic N staging was compared and survival analysis was performed. ResultsPathologic N2 was found in 19 (19%) patients and was more common in cN1b (4 of 8) than in cN1a group (15 of 91) (p=0.042). Overall or disease-free survival rate was not different between cN1a and cN1b in the pathologic non-N2 (p=0.723, 0.905) or in pathologic N2 (p=0.954, 0.607) subgroups. ConclusionClinical N1 on PET-CT is heterogeneous in its pathologic staging and multiple clinical N1 is more related to pathologic N2 than single clinical N1. More cases are needed to show the prognostic significance of multiple clinical N1-pathologic N2.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 50 条
  • [1] Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer
    Bostantzoglou, Clementine
    Iliopoulou, Marianthi
    Hardavella, Georgia
    [J]. BREATHE, 2018, 14 (04) : 342 - 344
  • [2] Outcome of Surgical Treatment for Clinical N1 Non-Small Cell Lung Cancer
    Nemoto, D.
    Ito, H.
    Tsuboi, T.
    Eriguchi, D.
    Samejima, J.
    Nagashima, T.
    Nakayama, H.
    Masuda, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S909 - S909
  • [3] Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer
    Watanabe, S
    Asamura, H
    Suzuki, K
    Tsuchiya, R
    [J]. ANNALS OF THORACIC SURGERY, 2005, 79 (05): : 1682 - 1685
  • [4] Problems in the current diagnostic standards of clinical N1 non-small cell lung cancer
    Hishida, T.
    Yoshida, J.
    Nishimura, M.
    Nishiwaki, Y.
    Nagai, K.
    [J]. THORAX, 2008, 63 (06) : 526 - 531
  • [5] Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer
    Masaya Tamura
    Isao Matsumoto
    Yusuke Tanaka
    Daisuke Saito
    Shuhei Yoshida
    Munehisa Takata
    Hirofumi Takemura
    [J]. General Thoracic and Cardiovascular Surgery, 2020, 68 : 261 - 265
  • [6] Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer
    Tamura, Masaya
    Matsumoto, Isao
    Tanaka, Yusuke
    Saito, Daisuke
    Yoshida, Shuhei
    Takata, Munehisa
    Takemura, Hirofumi
    [J]. GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2020, 68 (03) : 261 - 265
  • [7] Definitive Hypofractionated Radiation in the Treatment of Clinical N1 Non-Small Cell Lung Cancer (NSCLC)
    Gits, Colton C.
    Rehman, Sana
    Roach, Michael C.
    Speirs, Christina K.
    Chundury, Anupama
    Henke, Lauren
    Mullen, Daniel
    DeWees, Todd
    Bradley, Jeffrey D.
    Robinson, Clifford G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E37 - E37
  • [8] Results of N1 and N2 surgery in non-small cell lung cancer
    Pfannschmidt, J.
    Kollmeier, J.
    [J]. CHIRURG, 2019, 90 (12): : 974 - 981
  • [9] Prognosis of Unexpected and Expected Pathologic N1 Non-Small Cell Lung Cancer
    Shin, Sumin
    Kim, Hong Kwan
    Choi, Yong Soo
    Kim, Kwhanmien
    Kim, Jhingook
    Shim, Young Mog
    [J]. ANNALS OF THORACIC SURGERY, 2013, 96 (03): : 969 - 976
  • [10] Segmentectomy vs Lobectomy for Pathological N1 Non-Small Cell Lung Cancer
    Chan, Patrick
    Mazur, Summer
    Chan, Ernest
    Awais, Omar
    Levy, Ryan
    Pennathur, Arjun
    Nason, Katie
    Luketich, James
    Schuchert, Matthew
    [J]. CHEST, 2017, 152 (04) : 662A - 662A